GlassScriptPhysician profile
Mark P Trolice
NPI 1407866809
$3,541.61
in general payments reported to CMS, 2019-2025
12 companies · $21.24 in 2025
The $21.24 reported for 2025 was less than what a typical Reproductive Endocrinology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,327 · 2020: $107 · 2021: $715 · 2022: $371 · 2025: $21.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $21.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $1,748.35 | 2019-2021 | |
| Abbvie INC. | $590.45 | 2019-2021 | |
| Coopersurgical, INC. | $387.09 | 2021-2025 | Origio Sequential Fert |
| Vitrolife INC. | $215.40 | 2022 | |
| Hologic Sales and Service, LLC | $174.98 | 2021-2022 | |
| Roche Diagnostics Corporation | $106.82 | 2020 | |
| Gauss Surgical INC. | $99.87 | 2019 | |
| Becton, Dickinson and Company | $77.65 | 2019 | |
| Asensus Surgical, INC. | $74.34 | 2021 | |
| Merck Sharp & Dohme LLC | $39.44 | 2019 | |
| Medtronic, INC. | $14.27 | 2021 | |
| Olympus America INC. | $12.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Trolice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.